Incyte Announces Positive Results from Phase 3 Trial Evaluating Retifanlimab (Zynyz ®) in Combination with Platinum-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer
” Phase 3 POD1UM-304 trial met primary endpoint of overall survival (OS)…
